SynInnova Laboratories Inc.

SL-3339

4-Defluoro-4-hydroxy gefitinib, 98%

CAS No. :

[847949-50-2]

Synonyms : 2-Chloro-4-((7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-yl)amino)phenol

Price and Availability
Pack Size	Price in USD	Quantity	Availability	Shipping Status
25MG	120.00	- +	Back Order	Estimated to Ship on 12.20.2024
250MG	980.00	- +	Back Order	Estimated to Ship on 12.20.2024

Chemical Properties
Mol. Formula : C₂₂H₂₅ClN₄O₄	Mol. Weight : 444.91
Appearance : Solid	Melting Point : Not available
For Laboratory research use only, not for drug, household or other uses.

Applications : This is a metabolite of Gefitinib, which is an orally active epidermal growth factor receptor tyrosine kinase inhibitor that blocks signal pathways implicated in solid tumour growth and metastasis.

References : Ranson M.et.al.: J.Clin. Pharm.Ther., 29(2), 95, 2004.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.

To receive price and delivery information on larger quantities, please complete the form below and we will respond promptly.

If you login prior to completion of the form, your contact information will automatically populate.

Your request for quote will also be accepted by e-mail at sales@syninnova.com or Fax: +1 780 485 2963.

Product ID : SL-3339

Product Name : 4-Defluoro-4-hydroxy gefitinib

Note : If you do not find your required compound in our catalogue, or not commercially available, please contact us, we will assist you to get your desired molecule. We only charge if we deliver to your satisfaction.

Site is under construction and it will coming soon. Please contact us at sales@syninnova.com for COA. Thank you!

Site is under construction and it will coming soon. Please contact us at sales@syninnova.com for HNMR. Thank you!

Related Products

SL-3329	Gefitinib-d₈
SI-035	4-Methoxy-5-(3-morpholine-4-propoxy)-2-nitrobenzonitrile
SL-3345	Gefitinib impurity 1
SL-3343	7-Methoxy-4-oxo-3,4-dihydroquinazolin-6-yl acetate
SL-3333	Gefitinib EP impurity A
SL-3330	Gefitinib-d₆
SL-3336	3-Deschloro-3,4-difluoro gefitinib
SL-3351	O-Desmorpholinopropyl gefitinib
SL-3337	4-Desfluoro gefitinib
SI-2478	Gefitinib
SL-3354	3-(3-Chloro-4-fluorophenyl)-6-hydroxy-7-methoxyquinazolin-4(3H)-one
SL-3348	Gefitinib impurity 8

SL-3339	4-Defluoro-4-hydroxy gefitinib
SI-2832	(R)-((R)-2-(3,4-Dichlorophenyl)oxetan-2-yl)(pyridin-2-yl)methanol
SI-390	6-Phenylnicotinonitrile
SI-3023	(R)-1-(3,5-Dichloropyridin-4-yl)ethanol
SI-2216	Ethyl 5-cyano-2-(difluoromethyl)nicotinate
SI-3022	(S)-1-(3,5-Dichloropyridin-4-yl)ethanol
SA-635	2,3,4-Tri-O-acetyl-α-D-glucuronic acid methyl ester, trichloroacetimidate
SI-042	2-Bromo-5-(4-fluorobenzyl)-3-nitropyridine
SL-744	N-[2-(5-Methoxy-indol-3-yl)-ethyl]-commenamide
SL-885	Curcumin-β-D-glucuronide
SL-511	7-Hydroxycoumarin-4-acetic acid
SI-1476	5-Bromo-1H-pyrazolo[3,4-b]pyridin-3(2H)-one

SL-3339

4-Defluoro-4-hydroxy gefitinib, 98%

Recently Viewed Products

Related Products